SANA (MVD1)

SANA (MVD1) Research Standard

SANA (MVD1), chemically identified as 5-(2-nitroethenyl)salicylic acid, is a novel nitroalkene derivative of salicylate that serves as a specialized research tool for studying creatine-dependent thermogenesis. Distinct from classical incretin-based metabolic modulators (such as GLP-1 or GIP agonists), SANA (MVD1) is investigated for its capacity to directly influence energy expenditure at the adipocyte level. By upregulating creatine metabolism and promoting futile creatine cycling, it serves as a unique reference compound for exploring UCP1-independent and AMPK-independent thermogenic pathways.

Technical Specifications

Mechanism of Action & Research Context

SANA (MVD1) represents a distinct mechanistic class in metabolic research, focusing on the acceleration of ATP hydrolysis through futile cycles.

• Creatine-Dependent Thermogenesis: The compound is characterized by its ability to upregulate genes associated with creatine metabolism and enhance creatine kinase activity within adipose tissue.

• Thermogenic Pathway: Unlike classical brown adipose thermogenesis, which relies on Uncoupling Protein 1 (UCP1), SANA functions through a UCP1-independent pathway, driving heat output via the hydrolysis of ATP in a futile creatine cycling loop.

• Pathway Independence: Preclinical data suggests the compound operates independently of the canonical AMPK energy-sensor pathway, distinguishing it from pharmaceutical agents that modulate systemic appetite or metabolic signaling sensors.

• Lean Mass Preservation: Research models contrast the metabolic profile of SANA with that of incretin-based agonists, often citing its potential to preserve lean mass during periods of increased energy expenditure.

Research Applications

SANA (MVD1) is an essential reagent for laboratories investigating the nuances of adipose tissue metabolism and bioenergetics.

Primary fields of in vitro laboratory investigation include:

• Creatine-Dependent Thermogenesis: Mapping the specific molecular steps of creatine-driven futile cycling.

• Adipocyte Bioenergetics: Measuring direct energy expenditure and ATP hydrolysis rates in isolated adipose cells.

• Metabolic Comparative Research: Using SANA as a baseline to differentiate outcomes against incretin-class (GLP-1/GIP) compounds.

• Nitroalkene/Salicylate SAR Studies: Investigating the structure-activity relationship of nitroalkene derivatives on metabolic endpoints.

• UCP1-Independent Research: Utilizing the compound as a tool to bypass classical brown fat activation models.

Storage & Handling Guidelines

To maintain the chemical stability and experimental viability of the compound:

• Storage Environment: Store in a cool, dry place. Ensure the compound is protected from humidity to prevent degradation of the lyophilized powder.

• Light Sensitivity: Maintain in a light-protected environment, as nitroalkene compounds can be sensitive to photodegradation.

• Container Integrity: Keep the container tightly sealed when not in use to ensure atmospheric stability.

• Aseptic Technique: Handle with clean laboratory tools to prevent contamination of the reference material.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.